Welcome

1.2.公司產品布局領域豐富,在研管線潛力較大 公司以臨床需求為出發點,依據病種病機和病程的不同特點,針對

公司有權在收到告知書之日起五個交易日內申請聽證,或在十個交易日內提交書麵陳述和申辯。

Read More

Experience

臨床需求導向,多款重磅產品處於臨床階段截至20250630,公司處於臨床試驗階段的主要研發項目有:基因治療板塊的KH631、KH6

Read More

Resources

【簽大單】*ST鬆發:下屬公司簽訂6艘30.6萬噸超大型原油運輸船建造合同,合同金額約6-9億美元*ST鬆發公告,下屬公司恒力造船

Read More

Cases

除了高血糖作為主要的致病因素外,慢性炎症和神經退行性改變也可能加劇其病情。【增減持】嘉和美康:股東賽富璞鑫擬減持不超1.94%公司

Read More

News & Events

[10-08-2015]

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.

[10-08-2015]

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.